In this study, we aimed to assess the correlation between MMR status and TLSs in CRC and explore TLSs as predictive biomarkers for anti-PD-1 immunotherapy to facilitate more personalized treatment of patients with CRC with different MMR subtypes. Here, PDCD1 is linked to colorectal carcinoma.